Piramal Pharma Limited (PPLPHARMA.BO)
INR 221.45
(2.07%)
INR 221.45
(2.07%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 4.55 Billion INR | 1366.51% |
| 2022 | -359.8 Million INR | -109.63% |
| 2021 | 3.73 Billion INR | -32.11% |
| 2020 | 5.5 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.49 Billion INR | 649.2% |
| 2024 Q1 | 199.4 Million INR | -94.03% |
| 2023 Q1 | -412.9 Million INR | -124.75% |
| 2023 FY | 4.55 Billion INR | 1366.51% |
| 2023 Q4 | 3.33 Billion INR | 306.83% |
| 2023 Q3 | 820.5 Million INR | 1.13% |
| 2023 Q2 | 811.3 Million INR | 296.49% |
| 2022 Q2 | 63.7 Million INR | 104.41% |
| 2022 Q1 | -1.44 Billion INR | -162.1% |
| 2022 FY | -359.8 Million INR | -109.63% |
| 2022 Q4 | 1.66 Billion INR | 316.42% |
| 2022 Q3 | -771 Million INR | -1310.36% |
| 2021 Q2 | 927.4 Million INR | 0.0% |
| 2021 FY | 3.73 Billion INR | -32.11% |
| 2021 Q4 | 2.32 Billion INR | -6.2% |
| 2021 Q3 | 2.48 Billion INR | 167.61% |
| 2020 FY | 5.5 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 20.861% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 89.202% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 49.25% |
| Granules India Limited | 6.81 Billion INR | 33.151% |
| Indoco Remedies Limited | 1.29 Billion INR | -252.551% |
| Achyut Healthcare Limited | 4.43 Million INR | -102579.135% |
| Ajanta Pharma Limited | 19.67 Billion INR | 76.842% |
| Alkem Laboratories Limited | 19.46 Billion INR | 76.586% |
| Alpa Laboratories Limited | 184.49 Million INR | -2369.905% |
| Brooks Laboratories Limited | 14.44 Million INR | -31457.479% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | -165.322% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -270.178% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 93.272% |
| Eris Lifesciences Limited | 5.18 Billion INR | 12.058% |
| FDC Limited | 2.98 Billion INR | -52.598% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 29.92% |
| Gufic Biosciences Limited | 1.32 Billion INR | -242.647% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | -3.084% |
| Ipca Laboratories Limited | 7.98 Billion INR | 42.9% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -796.798% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 3098.809% |
| Lasa Supergenerics Limited | -458 Million INR | 1094.945% |
| Laurus Labs Limited | 3.94 Billion INR | -15.405% |
| Lupin Limited | 28.04 Billion INR | 83.751% |
| Mankind Pharma Limited | 21.51 Billion INR | 78.823% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Medico Remedies Limited | 100.3 Million INR | -4443.27% |
| Megasoft Limited | -121.1 Million INR | 3862.799% |
| NATCO Pharma Limited | 25.96 Billion INR | 82.448% |
| RPG Life Sciences Limited | 2.29 Billion INR | -98.792% |
| Sigachi Industries Limited | 1.47 Billion INR | -209.174% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 95.631% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 1.101% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -1728.237% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Wanbury Limited | 569.71 Million INR | -699.855% |
| Windlas Biotech Limited | 1.29 Billion INR | -250.83% |
| ZIM Laboratories Limited | 253.82 Million INR | -1695.264% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 89.429% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 210.738% |
| Divi's Laboratories Limited | 33.08 Billion INR | 86.225% |
| Hester Biosciences Limited | 364.81 Million INR | -1149.116% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -63.564% |
| Amrutanjan Health Care Limited | 457.54 Million INR | -895.948% |
| Bal Pharma Limited | 233.9 Million INR | -1848.151% |
| Strides Pharma Science Limited | 5.22 Billion INR | 12.8% |
| Venus Remedies Limited | 534.65 Million INR | -752.313% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -45.676% |
| Nectar Lifesciences Limited | 923.8 Million INR | -393.275% |
| Shilpa Medicare Limited | 1.36 Billion INR | -233.528% |
| Aarti Drugs Limited | 7.14 Billion INR | 36.256% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | -185.377% |
| Suven Life Sciences Limited | -1.22 Billion INR | 471.742% |
| Ind-Swift Limited | 1.22 Billion INR | -271.699% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 68.095% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 218.272% |
| Themis Medicare Limited | 392.58 Million INR | -1060.73% |
| Hikal Limited | 32.11 Million INR | -14091.529% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 82.014% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | -627.358% |
| Wockhardt Limited | -670 Million INR | 780.134% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 12.182% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -50148.657% |
| Neuland Laboratories Limited | 5.31 Billion INR | 14.313% |
| Morepen Laboratories Limited | 4.17 Billion INR | -9.178% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -2090.291% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -16495.892% |